Robotic-assisted laparoscopic urologic surgery is a major evolution in the field and has now become a major subspecialty. This issue of Urologic Clinics of North America aims to provide comprehensive, state-of-the-art information about the recent developments in the areas of Uro-Oncology, Reconstructive Urology, and Female Urology. Topics such as issue of training, evidence-based practice, the economics of robotic surgery, and the impact on public and global health are also covered.The contributors are truly pioneers and the best experts in the field.
**Selected for Doody's Core Titles® 2024 in Urology**Single-Port Robotic Surgery in Urology: The New Beginning After the Advent of Dedicated Platforms describes the novel field of robotic single-port urologic surgery. Recent advances in surgical robotics combined with the pursuit to reduce the invasiveness of laparoscopic surgery have led to the development of novel robotic platforms specifically designed for single-port surgery. This reference summarizes the state-of-the-art of robotic single-port urologic surgery. Coverage takes a three-part approach, providing a description of the technological evolution which led to the advent of novel platforms specifically designed for single-port surgery, describing the urological procedures that can be performed, and outcomes and potential drawbacks. - Provides a description of the current status of single-port robotic urologic surgery performed using novel dedicated platforms - Expands understanding on why single-port is better than the standard multi-arms robotic approach, highlighting an analysis of surgical steps - Summarizes data about each intervention, including pooled comparative analyses, to provide the most evidence-based examination possible
Under the direction of New Consulting Editor, Dr. Kevin Loughlin, Guest Editors Drs. Jim C. Hu and Jonathan Shoag have put together a state-of-the-art monograph on robotics in urologic surgery. Not only do expert authors present current status and advances in this field, but they also look at what the future of robotic urologic surgery will mean for urologists and patients. Clinical review articles are devoted to the following topics: Robotic Ureteral Reconstruction; Robotic Prostatectomy: Technical Modifications that Improve Outcomes; Robotic Radical Cystectomy; Robotic Urology Training; Robotic Prostatectomy Quality Improvements; Robotic Lower Urinary Tract Reconstruction; Incorporating AI into GU Endoscopy; Competing Robotic Systems: A Preview; Robotic Intracorporeal Diversion; Robotic Reconstruction in Pediatric Urology; Robotic Partial Nephrectomy: Update on Techniques; Robotics in Male Infertility; Transperineal Biopsy; Robotic-Assisted Surgery for Upper-Tract TCC; and Retzius-Sparing Robotic Prostatectomy. Urologists will come away with the information they need to stay on top of advances in the area of robotic surgery.
Urologists were early adaptors of robotic assisted laparoscopy, and pediatric urology similarly led in incorporating the technology into the surgical armamentarium for treating even the smallest infants. And it is in that tradition that this issue of Urologic Clinics of North America surveys the journey from the earliest pure laparoscopic procedures to the most advanced reconstruction possible today due to evolutions in technology. The issue begins with the procedure that arguably popularized the laparoscopic approach in pediatric urology—the laparoscopic orchiopexy, then posit the continued relevance of pure laparoscopy in the robotic era, before finally surveying contemporary advances in robotic-assisted pediatric urologic surgery. The issue is of relevance not only tor the novice contemplating a transition to laparoscopy or robotics but also for the seasoned minimally invasive surgeon seeking to enhance skills and augment his or her practice.
In this issue of Urologic Clinics of North America, guest editors Drs. Jeffrey M. Holzbeierlein and Philippe E. Spiess bring their considerable expertise to the topic of Advances in Penile and Testicular Cancer. Top experts in the field provide important clinical updates on the management of penile and scrotal cancer, discuss the current standards of care using evidence-based treatment guidelines, and provide insight on emerging discoveries. This issue provides critical information and updates needed to improve outcomes in patients with diseases that urologists do not see on a daily basis. - Contains 12 relevant, practice-oriented topics, including the psychosocial impact of penile cancer: an unmet need; what is on the horizon in clinical trials for penile and testicular cancer; the use of miRNA to predict teratoma and viable GCT after chemotherapy; testicular cancers survivorship and fertility preservation; and more. - Provides in-depth clinical reviews on advances in penile and testicular cancer, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
This issue of the Urologic Clinics will focus on urodynamic testing in men, women and special situations. Appropriate urodynamic testing options including video urodynamics, pressure flow studies, and neurogenic voiding discussion will be discussed. Dr. Nitti and Dr. Brucker have assembled well known experts in their fields to provide current clinical information for urodynamic evaluation, diagnosis, and treatment.
This issue provides much needed updates since Dr. Sheinfeld’s issue published in 2007. Dr. Lin has assembled expert authors to provide clinicians with the full breadth of clinical updates on testicular cancer. New to this issue are articles on clinical outcomes, survivorship, and several articles on the management of Nonseminomatous Germ Cell Tumors.
An estimated 234,000 new cases of prostate cancer will be diagnosed in the United States this year, making it one of the most common cancers affecting American men; however, it can be a controversial disease to diagnose and treat now that there is research abounding for both “watchful waiting and aggressive treatments. Dr. Oh supplies balanced information, with articles on: Prostate Cancer: To Screen or Not To Screen?; High Intensity Focused Ultrasound: Ready for Primetime?; The Case for Open vs. Robotic Assisted Laparoscopic Radical Prostatectomy; Primary and Salvage Prostate Cancer Cryotherapy; and The Case for Open vs. Robotic Assisted Laparoscopic Radical Prostatectomy, to name a few. The state-of-the art information presented in this issue make is must-have for all urologists.
PSA screening remains highly controversial due to several important disadvantages. More PSA is produced with prostatic enlargement and in other benign conditions such as urinary tract infections. False positive tests can then lead to unnecessary diagnostic workup with invasive prostate biopsy. Another major problem with screening programs in general is overdiagnosis of cancers that would not have caused harm during the patient's lifetime. For example, many prostate cancers have a relatively indolent behavior so may not require diagnosis or treatment in a patient with limited life expectancy. All forms of prostate cancer treatment have potential urinary and sexual side effects, so reducing overdiagnosis and overtreatment are critical public health issues. Because screening has many proven benefits but also significant harms, there are widely disparate guidelines on prostate cancer screening from major organizations worldwide. This issue of the Urologic Clinics will provide insights into the many different prostate cancer guidelines and related policy issues.
The guest editors, Dr. William Huang and Dr. Ezequiel Becher, have assembled a state-of-the art issue devoted to Advanced and Metastatic Renal Cell Carcinoma (RCC). They have secured expert authors to contribute clinical reviews on the important topics involving treating and managing patients with RCC. Specific articles are devoted to the following topics: Imaging for Metastatic RCC; Adjuvant Therapy for Localized High Risk RCC; Current Standards for Therapeutic Sequencing for Advanced RCC; Role of Lymphadenectomy in patients with advanced RCC; Cytoreductive Nephrectomy in the Era of TKI/IO - Who, When and Why; Minimally Invasive Surgery for Patients with Locally Advanced and Metastatic Disease RCC; Evolving Role of Urologists in the Management of Advanced RCC; Neoadjuvant Therapy for Locally Advanced RCC; Epidemiology and Risk Assessment/Biomarkers for Patients with Advanced RCC; Radiation Therapy for Patients with Metastatic RCC; Evolving Role of Metastatectomy for Patients with Metastatic RCC; and Management of Non-Clear Cell Metastatic RCC. Readers will come away with the information they need to treat and manage patients and to improve outcomes.
